EXACT Sciences Corporation (EXAS) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $103.25
• Market Cap: $19.71B
• EPS: $-1.10
• 52-Week High: $103.67
• 52-Week Low: $38.81

Market Sentiment

EXACT Sciences Corporation currently has a Bullish sentiment score of 0.42.

About EXACT Sciences Corporation

Exact Sciences Corporation is a pioneering company in cancer diagnostics, dedicated to enhancing early detection and treatment outcomes through its innovative screening and diagnostic tests. Based in Madison, Wisconsin, the firm is best known for its flagship Cologuard test, which significantly advances the early detection of colorectal cancer. With a commitment to transforming cancer care, Exact Sciences harnesses state-of-the-art technology and robust research initiatives to drive growth an...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for EXACT Sciences Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EXAS pay dividends?

EXACT Sciences Corporation (EXAS) does not currently pay a regular dividend.

What is EXAS's market cap?

EXACT Sciences Corporation (EXAS) has a market capitalization of $19.71B with a current stock price of $103.25.